Schedule a Meeting
Get a SampleFebruary 2025
The global chronic disease management market size is calculated at USD 6.61 billion in 2025 and is forecasted to reach around USD 20.87billion by 2034, accelerating at a CAGR of 13.62% from 2025 to 2034. The North America market size surpassed USD 2.33 billion in 2024 and is expanding at a CAGR of 13.74% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global chronic disease management market size accounted for USD 5.82 billion in 2024 and is predicted to increase from USD 6.61 billion in 2025 to approximately USD 20.87 billion by 2034, expanding at a CAGR of 13.62% from 2025 to 2034.The demand for chronic disease management is increasing due to the rising chronic disease prevalences especially in the urban areas due to the changing lifestyle patterns.
The rising adoption of technologies like artificial intelligence and machine learning in the healthcare sector is helping companies improve their services. The use of AI in imaging is helping in the early detection of diseases like diabetes which would help in taking precautionary measures. The use of AI tools helps in analyzing the patient history and lifestyle patterns which would help in generating personalized treatment plans.
The growing investments in chatbots and virtual assistants are anticipated to improve the overall management systems in healthcare organizations. The growing advancements in the healthcare sector are anticipated to witness advances in deep learning models which would help in detecting conditions from imaging like X-rays.
The U.S. chronic disease management market size was exhibited at USD 1.75 billion in 2024 and is projected to be worth around USD 6.38 billion by 2034, growing at a CAGR of 13.80% from 2025 to 2034.
North America dominated the global chronic disease management market in 2024. The rising healthcare expenditure in countries like the United States and Canada are the major players that are helping towards the growth. The digital availability in the region also makes their operations efficient. The United States is the major factor behind the growth of the region where the chronic disease prevalence is increasing rapidly. Factors like changing lifestyle contribute to the growth. The market is anticipated to rise rapidly, and the U.S. government is investing heavily in remote monitoring programs and services that serve the whole nation. The rising AI adoption by key industry players in the country is anticipated to boost the growth in the upcoming years too.
Asia Pacific is anticipated to emerge as the fastest-growing market during the forecast period of 2025 to 2034. The growth of the region is attributed to the rising healthcare expenditure in developing countries like India, Japan, and China. The advancements are also demanding advanced healthcare services in the region. The chronic disease management market in China remains dominant as the government is promoting digital health adoption like Healthy China 2030, aiming to prevent disease prevalence in the nation. The companies in the region are also adopting technologies that aim to prevent disease prevalence in urban areas.
Chronic condition management refers to the medical services with a planned approach to monitor and treat the individual health, suffering from medical conditions. These services focus on patient-centric care that enhances the patient’s lifestyle patterns, medications, and other needs. The chronic disease management market is growing rapidly, and the prevalence of diseases like hypertension, diabetes, CAD, obesity, and many more are increasing rapidly. Healthcare services are expanding due to the rising patient visits as these conditions last for a year or more. The healthcare companies are focusing on the improvement of the management which would help the market grow.
| Report Coverage | Details |
| Market Size by 2034 | USD 20.87 Billion |
| Market Size in 2025 | USD 6.61 Billion |
| Market Size in 2024 | USD 5.82 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 13.62% |
| Leading Region/ Dominated Region | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Type, Disease, End User,and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Advancements in wearables
Rapid digitalization is marking significant advancements that are helping individuals focus on their health through real-time health monitoring options. The chronic disease condition management market is growing due to the advancements in smartwatches and fitness bands that have enabled tracking of blood pressure, heart rate, etc which helps them to track their body condition regularly and opt for medical help if needed. This is helping in the rising number of patient visits where they are focusing on their fitness.
Increasing government investments
The rise in global disease prevalence is marking significant changes in the healthcare sector which would help in providing healthcare services at lower costs for all the patients. The chronic disease management market is growing rapidly the governments are investing heavily in monitoring platforms where they would boost the services for patients suffering from chronic diseases.
The National Digital Health Mission (NDHM) mission in India is supporting chronic disease tracking platforms. The governments are also investing in health screening campaigns that help individuals opt for regular checkups at lower or free costs. Moreover, they are focused on adopting the WHO NCD action plan which is focused on preventing diseases like CAD, diabetes, and obesity.
Resource limitations in the underdeveloped regions
The rising technological advancements in the healthcare sector are playing an influential role in developed economies, but there are still some factors that tend to affect market growth. The chronic disease management market can face certain challenges in low-income countries due to financial restrictions. This restrains them from adopting new technologies in their healthcare settings, which affects the medical outcomes.
Growth of telemedicine and remote monitoring
The rising digital adoption in healthcare is eliminating the physical and geographical barriers for the patients as the companies are adopting remote patient monitoring. The chronic disease management market is anticipated to grow rapidly, and companies are investing in virtual healthcare. For instance, the U.S. passed a bill Medicare Telehealth Expansion Act, which anticipated to promotion of chronic disease care management virtually.
Technological advancements are anticipated to help in these services by providing insights into the patient's health. The rising investments in the network infrastructure are also anticipated to boost telehealth services for patients in the rural areas which would help them in opting for healthcare services without physical visits.
Growth of personalized medicine
The rising technological adoption by healthcare organizations is anticipated to help in precision medicine, which would cure diseases like diabetes, cancer, and many more. Genetic testing is gaining significant investments as it helps provide personalized medicine to the patient and helps the market. These advancements are anticipated to help the outcomes of these diseases by reducing errors.
The chronic disease management market is anticipated to improve in the upcoming years when consumers opt for dietary modifications. AI is anticipated to help in innovating personalized platforms for diseases like diabetes. For instance, Livongo uses technology to track blood sugar levels and provides a report that further helps the treatment.
The solutions segment marked its dominance in the market by generating the highest share in 2024. The segment deals with the function of the software platforms, remote monitoring tools and wearable devices which are used for managing these medical conditions. The chronic disease management market is growing rapidly due to the rising adoption of technologies like AI, which boost the operational efficiency of this software. The rising adoption of remote monitoring is playing a crucial role in managing various conditions, which makes these services affordable through digitalization. For instance, the U.S. Chronic Care Management (CCM) is promoting digital tools for tracking these diseases.
The services segment is anticipated to grow at the fastest CAGR during the forecast period of 2025 to 2034. These services include telemedicine consultations, personalized coaching, and other digital services. The chronic disease management market is anticipated to grow rapidly due to rapid digitalization, which is increasing the number of virtual chronic care programs. The increasing technological adoption has also enabled personalized coaching, which aims to cure these conditions in the long term.
The diabetes segment led the global market in 2024. The chronic disease management market is witnessing significant initiatives that aim to expand medical solutions for these diseases. The urban areas have adopted sedentary lifestyles, which leads to obesity that often leads to type 2 diabetes. The rising prevalence is also marking significant initiatives like insurance coverage that are increasing the demand for these services. The companies are anticipated to expand rapidly as they are focusing on insulin pumps and digital health innovation.
The cardiovascular diseases segment is anticipated to grow at the highest CAGR during the forecast period of 2025 to 2034. The rising prevalence of hypertension, high cholesterol, and strokes is one of the major factors that is anticipated to boost the demand for the chronic disease management market. The companies are focusing on innovations like wearables that track real-time data of the patients and help in enhancing medical treatment plans. The companies are also aiming to promote virtual care which would help in increasing the patient volume. For instance, Clevland Clinic has launched a 12-week home-based cardiac rehab program aiming to promote a heart-healthy lifestyle. The companies are also investing in cardiology which would increase the business opportunities for chronic disease management in the upcoming years.
The healthcare provider segment stood the dominant in the market in 2024. The providers are mainly hospitals, telemedicine providers, and other primary care centers. The chronic disease management market is advancing at a rapid pace where, the hospitals are focusing on adopting advanced tools and professionals that would improve treatment outcomes. This makes them reliable and dominant due to the higher patient volume in these settings. The rising investments are promoting technological adoption which is used to measure patient health.
The healthcare payers segment is anticipated to grow as the fastest growing during the forecast period of 2025 to 2034. The growth of the segment is attributed to the rising healthcare insurance policies that help individuals manage their healthcare costs. The rising health awareness is leading to an increasing number of policies that aim to cover all the category populations. These initiatives are anticipated to create value-based care which would help in tracking and preventing diseases at early stages. The governments are creating policies that would increase the reimbursement rate for individuals.
By Disease Type
By Type
By End-User
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
February 2025
May 2024
November 2024
August 2024